Indian scientists flag coronavirus mutations that could ‘evade immune response’

Published May 2, 2021
People get their names registered after receiving a dose of Covishield, a Covid-19 vaccine manufactured by Serum Institute of India, at a vaccination centre in Ahmedabad, India, May 1. — Reuters
People get their names registered after receiving a dose of Covishield, a Covid-19 vaccine manufactured by Serum Institute of India, at a vaccination centre in Ahmedabad, India, May 1. — Reuters

A forum of scientific advisers set up by the Indian government has told authorities about minor mutations in some samples of the coronavirus that could “possibly evade immune response” and require more study, a leader of the forum has told Reuters.

However, the advisers said while they were flagging the mutations, there was no reason currently to believe they were expanding or could be dangerous.

Scientists are studying what led to the current surge in cases in India and particularly whether a variant first detected in the country, called B.1.617, is to blame. The World Health Organisation (WHO) has not declared the Indian variant a “variant of concern,” as it has done for variants first detected in Britain, Brazil and South Africa. But the WHO said on April 27 that its early modelling, based on genome sequencing, suggested that B.1.617 had a higher growth rate than other variants circulating in India.

The forum of advisers, known as the Indian SARS-CoV-2 Genetics Consortium, or INSACOG, has now found more mutations in the coronavirus that it thinks need to be tracked closely.

"We are seeing some mutation coming up in some samples that could possibly evade immune responses," said Shahid Jameel, chair of the scientific advisory group of INSACOG and a top Indian virologist. He did not say if the mutations have been seen in the Indian variant or any other strain.

"Unless you culture those viruses and test them in the lab, you can't say for sure. At this point, there is no reason to believe that they are expanding or if they can be dangerous, but we flagged it so that we keep our eye on the ball," he said.

INSACOG brings together 10 national research laboratories.

India reported more than 400,000 new Covid-19 cases for the first time on Saturday. The rampaging infections have collapsed its health system in places including capital New Delhi, with shortages of medical oxygen and hospital beds.

Opinion

Gaming LNG
Updated 05 Aug 2021

Gaming LNG

What looked like rank incompetence about a year ago is now beginning to smack of malfeasance.
Healing the spirit
05 Aug 2021

Healing the spirit

ROC medal winners could not hear their national anthem being played.
Returning to a repressive order
Updated 04 Aug 2021

Returning to a repressive order

There is no sign of the Taliban showing any flexibility in their position and taking a more moderate stance.

Editorial

A tragic anniversary
Updated 05 Aug 2021

A tragic anniversary

Attempts to change IOK's demography should end and India must open channels with the genuine Kashmiri leadership.
05 Aug 2021

Currency pressure

THE increasing demand for dollars in the wake of surging imports and debt repayments has put significant pressure on...
05 Aug 2021

Protecting breastfeeding

A LOT has been said about the fact that 40pc of children under five years in Pakistan are stunted. The reasons...
PML-N’s dilemma
Updated 04 Aug 2021

PML-N’s dilemma

The road ahead for the PML-N is going to be long and bumpy no matter which narrative it follows.
04 Aug 2021

Attacks on cops

AMIDST cautious optimism that Pakistan may be finally beginning to achieve success in bringing the number of polio...
04 Aug 2021

Myanmar about-face

SIX months into the coup that sent Myanmar’s hybrid civ-mil government packing, the generals have made their...